Abstract:http://aasldpubs.onlinelibrary.wiley.com/hub/journal/10.1002/(ISSN)2046-2484/video/14-5-reading-patel a video presentation of this article
http://aasldpubs.onlinelibrary.wiley.com/hub/journal/10.1002/(ISSN)2046-2484/video/14-5-interview-patel the interview with the author
“…Polycystic liver disease (with or without kidney involvement) is broadly defined as greater than 20 epithelial-lined biliary cysts. 40 The most common form, autosomal dominant polycystic kidney disease (ADPKD), results from mutations most often in the PKD1 or PKD2 genes (although in many cases no mutation is identified). Less common is the autosomal recessive polycystic kidney disease associated with congenital hepatic fibrosis.…”
Section: Chronic Kidney Injurymentioning
confidence: 99%
“…Massive hepatomegaly and compressive symptoms may occur, including esophageal reflux, nausea, vomiting, early satiety, weight loss, abdominal distention or pain, and dyspnea. 40 The hepatic severity is graded A (mildest) through D (most severe) based on the degree of symptoms and the number of hepatic segments that contain cysts. 41 The presence of diffuse hepatic cysts with severe symptoms designates class C, whereas class D also includes the presence of portal or hepatic vein occlusion due to the cysts.…”
This review will discuss the etiologies of kidney disease in liver transplant candidates, provide a historical background of the prior evolution of simultaneous liver–kidney (SLK) transplant indications, discuss the current indications for SLK including Organ Procurement and Transplantation Network policies and Model for End Stage Liver Disease exception points, as well as provide an overview of the safety net kidney transplant policy. Finally, the authors explore unanswered questions and future research needed in SLK transplantation.
“…Polycystic liver disease (with or without kidney involvement) is broadly defined as greater than 20 epithelial-lined biliary cysts. 40 The most common form, autosomal dominant polycystic kidney disease (ADPKD), results from mutations most often in the PKD1 or PKD2 genes (although in many cases no mutation is identified). Less common is the autosomal recessive polycystic kidney disease associated with congenital hepatic fibrosis.…”
Section: Chronic Kidney Injurymentioning
confidence: 99%
“…Massive hepatomegaly and compressive symptoms may occur, including esophageal reflux, nausea, vomiting, early satiety, weight loss, abdominal distention or pain, and dyspnea. 40 The hepatic severity is graded A (mildest) through D (most severe) based on the degree of symptoms and the number of hepatic segments that contain cysts. 41 The presence of diffuse hepatic cysts with severe symptoms designates class C, whereas class D also includes the presence of portal or hepatic vein occlusion due to the cysts.…”
This review will discuss the etiologies of kidney disease in liver transplant candidates, provide a historical background of the prior evolution of simultaneous liver–kidney (SLK) transplant indications, discuss the current indications for SLK including Organ Procurement and Transplantation Network policies and Model for End Stage Liver Disease exception points, as well as provide an overview of the safety net kidney transplant policy. Finally, the authors explore unanswered questions and future research needed in SLK transplantation.
“…PLD may be part of autosomal dominant polycystic liver disease (ADPLD) or extrarenal manifestation of autosomal dominant polycystic kidney disease (ADPKD); with the latter is more common. 1,2 Several diagnostic criteria have been published to differentiate between ADPLD and ADPKD. Distinguishing ADPKD with ADPLD is important as the monitoring protocol, management, and prognosis may vary greatly.…”
Section: Introductionmentioning
confidence: 99%
“…2 ADPKD is a multisystemic and progressive disease characterized by cyst formation in kidney and other organs which warranted routine renal function monitoring because the risk of developing end stage renal disease. 1 Evaluation regarding the burden of PLD is warranted; because PLD is often mistakenly as benign disease and no treatment required. Treatment is indicated in symptomatic patients.…”
Section: Introductionmentioning
confidence: 99%
“…Liver transplantation is the only definitive cure for PLD. [1][2][3] Until now, there is no specific guideline published for PLD. Here, we present a recently symptomatic 73-year-old-female with PLD and acute cholecystitis.…”
Polycystic liver disease is characterized by multiple cystic lesions on the liver. Liver cysts are typically incidental findings, with occasional complications including cyst hemorrhage, infection and rupture. Polycystic liver disease may be part of autosomal dominant polycystic liver disease (ADPLD). Autosomal dominant polycystic liver disease is considered rare autosomal dominant disease, with prevalence of 1/100,000-1,000,000. Without family history of polycystic liver disease, ADPLD is defined as the presence of more than 20 liver cysts with no renal cysts, however up to third of ADPLD may have small number of renal cysts without kidney function impairment. This case of a 73-year-old woman with symptomatic polycystic liver disease, and we performed cyst fenestration-deroofing via laparoscopic.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.